To evaluate selective target modulation by YTPs in cellular systems, we engineered a stable YTP-resistant TEAD1V406A/E408A variant of the TEAD1-dependent, YAP-amplified glioma line SF-268, which maintains its interaction with endogenous YAP and TAZ. The gene discussed is YAP1; the disease is central nervous system cancer.